Skip to main content
. 2019 Feb;14(2):242–255. doi: 10.4103/1673-5374.244784

Figure 1.

Figure 1

Changes in microRNA expression in blood serum, blood plasma, and cerebrospinal fluid (CSF) of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) patients compared to normal controls as indicated by polymerase chain reaction/real-time polymerase chain reaction (PCR/RT-PCR) screening and validation assays in the articles reviewed.

Increased or decreased expression is indicated by arrows pointing upwards or downwards, respectively. Color code is AD (red) and MCI (blue).